A case of complete androgen insensitivity syndrome with malignant mixed germ cell tumors

2011 ◽  
Vol 54 (11) ◽  
pp. 701
Author(s):  
Kyung-Hee Lee ◽  
You-Jin Lim ◽  
Jong-Shim Lee ◽  
Mi-Sung Kim ◽  
Jeong-Hyeon Jo ◽  
...  
Keyword(s):  
Germ Cell ◽  
Germ Cell Tumors ◽  
Androgen Insensitivity Syndrome ◽  
Complete Androgen Insensitivity Syndrome ◽  
Androgen Insensitivity ◽  
Mixed Germ Cell Tumors

scholarly journals Complete androgen insensitivity syndrome: factors influencing gonadal histology including germ cell pathology

2013 ◽  
Vol 27 (5) ◽  
pp. 721-730 ◽  
Author(s):  
Jana Kaprova-Pleskacova ◽  
Hans Stoop ◽  
Hennie Brüggenwirth ◽  
Martine Cools ◽  
Katja P Wolffenbuttel ◽  
...  
Keyword(s):  
Germ Cell ◽  
Androgen Insensitivity Syndrome ◽  
Complete Androgen Insensitivity Syndrome ◽  
Androgen Insensitivity ◽  
Factors Influencing ◽  
Gonadal Histology

scholarly journals Complete Androgen Insensitivity Syndrome: From Bench to Bed

2021 ◽  
Vol 22 (3) ◽  
pp. 1264
Author(s):  
Nina Tyutyusheva ◽  
Ilaria Mancini ◽  
Giampiero Igli Baroncelli ◽  
Sofia D’Elios ◽  
Diego Peroni ◽  
...  
Keyword(s):  
Receptor Gene ◽  
Hormone Replacement ◽  
Basic Research ◽  
Well Being ◽  
Androgen Receptor Gene ◽  
Androgen Insensitivity Syndrome ◽  
Primary Amenorrhea ◽  
Complete Androgen Insensitivity Syndrome ◽  
Androgen Insensitivity

Complete androgen insensitivity syndrome (CAIS) is due to complete resistance to the action of androgens, determining a female phenotype in persons with a 46,XY karyotype and functioning testes. CAIS is caused by inactivating mutations in the androgen receptor gene (AR). It is organized in eight exons located on the X chromosome. Hundreds of genetic variants in the AR gene have been reported in CAIS. They are distributed throughout the gene with a preponderance located in the ligand-binding domain. CAIS mainly presents as primary amenorrhea in an adolescent female or as a bilateral inguinal/labial hernia containing testes in prepubertal children. Some issues regarding the management of females with CAIS remain poorly standardized (such as the follow-up of intact testes, the timing of gonadal removal and optimal hormone replacement therapy). Basic research will lead to the consideration of new issues to improve long-term well-being (such as bone health, immune and metabolic aspects and cardiovascular risk). An expert multidisciplinary approach is mandatory to increase the long-term quality of life of women with CAIS.

Sign in / Sign up

Export Citation Format

Share Document